Ovarian Cancer – Bradley Monk, MD, and Robert Figlin, MD, discuss clinical highlights from ESMO 2018

Ovarian Cancer – Bradley Monk, MD, and Robert Figlin, MD, discuss clinical highlights from ESMO 2018

Wednesday October 24, 2018

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Bradley Monk, MD, FACOG, FACS, Professor and Director of the Division of Gynecologic Oncology at Creighton University School of Medicine, discuss BRCA1+ ovarian patients, PARP inhibitors and the results of the SOLO-1 clinical trial

Featured Videos

Shirish Madhav Gadgeel, MBBS, regarding the top stories in lung cancer from ASCO 2019

Parameswaran Hari, MD, elaborates on the outcome from the ECOG trial in SMM

Sandip Patel, MD, speculates on the impact of the RELAY trial presented at ASCO 2019